The PESTO trial is no longer taking participants. 

The trial is a prospective multicentre trial to determine whether the drug etanercept, which is commonly used to treat other illnesses, is effective in helping relieve some symptoms of stroke.

As part of the trial, participants underwent baseline assessments and received an injection of etanercept or a placebo, with follow-up assessments.

A scientific paper about the study is due to be published in 2024.

Research team